GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (BOM:500126) » Definitions » Deferred Tax

Procter & Gamble Health (BOM:500126) Deferred Tax : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Procter & Gamble Health Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Procter & Gamble Health's change in deferred tax for the three months ended in Dec. 2024 was ₹0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Procter & Gamble Health Deferred Tax Historical Data

The historical data trend for Procter & Gamble Health's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health Deferred Tax Chart

Procter & Gamble Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23 Jun24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 143.10 122.70

Procter & Gamble Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Procter & Gamble Health Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procter & Gamble Health Deferred Tax Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Procter & Gamble Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (BOM:500126) » Definitions » Deferred Tax
Comparable Companies
BOM:544222 BOM:543748 BOM:530549 BOM:531599 NSE:STAR BOM:532482 NSE:INNOVACAP BOM:524735 BOM:506690 BOM:532872 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
PGHL:India
Address
Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Website
https://www.pghealthindia.com
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health Headlines

No Headlines